energy resources of aust (ERA:ASX)

Executive Profile*

Background*

Mr. Daniel S. Janney, MBA, Dan, serves as the Managing Director at SARcode Bioscience, Inc. and Alta Partners. He joined Alta Partners in February 1996 and focuses on investments in biopharmaceutical products and therapeutics. Mr. Janney served as a General Manager of Operations at Energy Resources of Australia Ltd. since April 1, 2009. Mr. Janney was also a Co-Founder of Alta BioPharma effort. He has been directly involved in the funding and development of over 25 ... life sciences companies. Mr. Janney served as a Senior Investment Banker at Montgomery Securities Limited where his responsibilities included public offerings, strategic advisory assignments, and advice on mergers, acquisitions, and divestitures for life sciences companies. From 1993 to 1996, Mr. Janney served as the Vice President in the Health Care Investment Banking Group of Montgomery Securities Health Care and at Biotechnology Investment Banking Group where he focused on financing high growth companies from January 1994 to April 1996. In addition, for several years, Mr. Janney was in the Private Equity Leveraged Buyout Group at Bankers Trust Company. He also led Alta’s investments in Ilex Oncology. He serves as the Director of Alba Therapeutics Corporation. He has been a Director of CoTherix Inc. since April 2001 and LJL Biosystems Inc. since June 1997. He serves as a Director of Esperion Therapeutics, Prolacta Bioscience, Kiadis Pharma, 7TM Pharma A/S, Acureon Pharmaceuticals, Inc., Cellective Therapeutics, Inc., SARcode Bioscience, Inc., Opal Therapeutics Pty Limited, InSync Research, Inc., Kémia, Inc., Arête Therapeutics, Inc., ViroBay, Inc., Lithera, SilverHaze Partners LLC, DiscoveRx Corporation, and Definity Health Corporation. He served as the Chairman of Arête Therapeutics, Inc. He served as the Chairman of Board of Directors of Dynavax Technologies Corporation from December 1996 to February 2006 and its Director from December 1996 to August 2006. Mr. Janney served as a Director of Chemgenex Pharmaceuticals Ltd. from February 8, 2007 to June 2011, Anesiva, Inc. from November 2000 to December 2005, Endeavor Pharmaceuticals, Inc. since 2000, Corgentech Inc. since November 2000, and Phenomix Corporation since February 2002. Mr. Janney served as a Director of CornerHardware.com, Inc., Vitra Bioscience, Inc., TransMedics, Inc. and Endonetics, Inc. (Endonetics Corporation). He serves as a Member of the Advisory Board for the Rebecca and John Moores Cancer Center at University of California, San Diego. Mr. Janney holds a Bachelor of Arts degree in History from Georgetown University in 1987 and a Master of Business Administration degree in Finance from the Anderson School at the University of California, Los Angeles 1991.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ERA:AU	A$1.04 AUD	+0.005

COMPETITOR COMPENSATION